{"id":334433,"date":"2026-11-02T10:45:26","date_gmt":"2026-11-02T05:15:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=334433"},"modified":"2026-11-02T10:45:26","modified_gmt":"2026-11-02T05:15:26","slug":"largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap High Quarterly Margin and Low Debt Stocks to Watch for Future Multibagger Potential: TCS, Sun Pharma, Pidilite and Indian Hotels"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>TCS Rs 2,502.60. Sun Pharma Rs 1,777.70. Pidilite Rs 1,461.60. Indian Hotels Rs 811.65. Market caps from Rs 1.12 lakh crore to Rs 8.31 lakh crore. Data as of 30 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">TCS, Sun Pharma, Pidilite and Indian Hotels are the 4 picks in this high quarterly margin and low debt stocks watchlist, with market caps between Rs 1.12 lakh crore and Rs 8.31 lakh crore. TCS stands out for the highest return on equity at 43.37%, while Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. PE ratios run from 16.03 to 56.50, so compare each one with its industry PE before investing. All figures are as of 30 October 2026.<\/p>\n<\/p><\/div>\n<p>High quarterly margin and low debt stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. TCS, Sun Pharma, Pidilite and Indian Hotels meet that test, with market caps from Rs 1.12 lakh crore to Rs 8.31 lakh crore and TCS offering the highest return on equity at 43.37%. Each of these companies has a latest quarter operating margin of at least 20 per cent and a debt to equity ratio below 0.3, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a latest quarter operating margin of at least 20 per cent and a debt to equity ratio below 0.3, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening high quarterly margin and low debt stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=high-quarterly-margin-and-low-debt-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#What_Are_High_Quarterly_Margin_and_Low_Debt_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are High Quarterly Margin and Low Debt Stocks and Why Do They Attract Multibagger Interest?\">What Are High Quarterly Margin and Low Debt Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#High_Quarterly_Margin_and_Low_Debt_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"High Quarterly Margin and Low Debt Stocks at a Glance: Price, Market Cap, PE and ROE\">High Quarterly Margin and Low Debt Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#TCS_Return_on_Equity_of_4337\" title=\"TCS: Return on Equity of 43.37%\">TCS: Return on Equity of 43.37%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Pidilite_Return_on_Equity_of_2261\" title=\"Pidilite: Return on Equity of 22.61%\">Pidilite: Return on Equity of 22.61%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Indian_Hotels_Quarterly_Profit_Up_2239\" title=\"Indian Hotels: Quarterly Profit Up 22.39%\">Indian Hotels: Quarterly Profit Up 22.39%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#High_Quarterly_Margin_and_Low_Debt_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"High Quarterly Margin and Low Debt Stocks: Financial Comparison on Growth and Margins\">High Quarterly Margin and Low Debt Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\" title=\"Institutional Holding in TCS, Sun Pharma, Pidilite and Indian Hotels\">Institutional Holding in TCS, Sun Pharma, Pidilite and Indian Hotels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_High_Quarterly_Margin_and_Low_Debt_Stocks\" title=\"Risks to Weigh in High Quarterly Margin and Low Debt Stocks\">Risks to Weigh in High Quarterly Margin and Low Debt Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_High_Quarterly_Margin_and_Low_Debt_Stocks\" title=\"How to Choose Between High Quarterly Margin and Low Debt Stocks\">How to Choose Between High Quarterly Margin and Low Debt Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_High_Quarterly_Margin_and_Low_Debt_Stocks_to_Watch\" title=\"Frequently Asked Questions on High Quarterly Margin and Low Debt Stocks to Watch\">Frequently Asked Questions on High Quarterly Margin and Low Debt Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Which_are_the_best_high_quarterly_margin_and_low_debt_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best high quarterly margin and low debt stocks to watch for multibagger potential?\">Which are the best high quarterly margin and low debt stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Is_TCS_a_good_stock_for_long-term_investors\" title=\"Is TCS a good stock for long-term investors?\">Is TCS a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\" title=\"What is the market cap of TCS, Sun Pharma, Pidilite and Indian Hotels?\">What is the market cap of TCS, Sun Pharma, Pidilite and Indian Hotels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_high_quarterly_margin_and_low_debt_stocks\" title=\"What are the risks of investing in high quarterly margin and low debt stocks?\">What are the risks of investing in high quarterly margin and low debt stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#Why_is_Pidilite_trading_at_a_PE_of_5650\" title=\"Why is Pidilite trading at a PE of 56.50?\">Why is Pidilite trading at a PE of 56.50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\" title=\"How much do institutions hold in TCS, Sun Pharma, Pidilite and Indian Hotels?\">How much do institutions hold in TCS, Sun Pharma, Pidilite and Indian Hotels?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_High_Quarterly_Margin_and_Low_Debt_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are High Quarterly Margin and Low Debt Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>High quarterly margin and low debt stocks are shares of large companies that kept at least twenty paise of operating profit from every rupee of sales in the latest quarter and carry very little debt, so a rich current margin sits on a clean balance sheet. The four here cover IT services, pharmaceuticals, adhesives and hotels.<\/p>\n<p>A high margin in the latest quarter shows that pricing power and cost control are working now, and low debt means that the extra profit is not eaten up by interest. For high quarterly margin and low debt stocks, both FY26 and the latest quarter showed growth. Whichever way you read high quarterly margin and low debt stocks, the common thread is rising profit backed by complete financial data. With high quarterly margin and low debt stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for high quarterly margin and low debt stocks are complete. Read each company&#8217;s latest results and exchange filings before acting on high quarterly margin and low debt stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"High_Quarterly_Margin_and_Low_Debt_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>High Quarterly Margin and Low Debt Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 30 October 2026. TCS combines the lowest PE of the group, 16.03, with the highest return on equity, 43.37%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/tcs\/tata-consultancy-services-ltd-share-price-today\">Tata Consultancy Services<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,502.60<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,31,455<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.03<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.27<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">43.37%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,976.80 to 3,350.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,777.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,27,161<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.25<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pidilitind\/pidilite-industries-ltd-share-price-today\">Pidilite Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,461.60<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,51,179<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.15<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.61%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.04<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,259.00 to 1,707.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indhotel\/the-indian-hotels-company-ltd-share-price-today\">Indian Hotels Company<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">811.65<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,12,493<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48.72<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.22<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">568.70 to 971.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"TCS_Return_on_Equity_of_4337\"><\/span><strong>TCS: Return on Equity of 43.37%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>TCS is India&#8217;s largest IT services company by market capitalisation and runs large AI and data practices for global clients. It reported FY26 revenue of Rs 2,71,423 crore, up 4.68% year on year, and net profit of Rs 49,454 crore, up 1.35%. Net profit has compounded at 6.49% a year since FY22, while revenue has grown 8.51% a year. Operating margin was 27.07% in FY26. The debt-to-equity ratio is 0.10, which keeps interest costs low.<\/p>\n<p>In the September 2026 quarter, revenue rose 11.79% to Rs 74,525 crore and net profit grew 14.86% to Rs 13,934 crore. Domestic institutions raised their holding from 12.01% in June 2025 to 13.47% in June 2026. The stock trades at a PE of 16.03 against an industry PE of 18.27, below the sector average, with a return on equity of 43.37%. The dividend yield is 4.79%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 35.25 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pidilite_Return_on_Equity_of_2261\"><\/span><strong>Pidilite: Return on Equity of 22.61%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pidilite Industries makes Fevicol, Dr. Fixit and other adhesives and construction chemicals. It reported FY26 revenue of Rs 14,867.01 crore, up 11.05% year on year, and net profit of Rs 2,470.72 crore, up 17.87%. Net profit has compounded at 19.62% a year since FY22, while revenue has grown 10.54% a year. Operating margin was 25.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 20.96% to Rs 4,643.55 crore and net profit grew 30.29% to Rs 883.51 crore. Domestic institutions raised their holding from 9.15% in June 2025 to 9.88% in June 2026. The stock trades at a PE of 56.50 against an industry PE of 36.15, with a return on equity of 22.61%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Indian_Hotels_Quarterly_Profit_Up_2239\"><\/span><strong>Indian Hotels: Quarterly Profit Up 22.39%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.<\/p>\n<p>The stock trades at a PE of 48.72 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 658.38% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"High_Quarterly_Margin_and_Low_Debt_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>High Quarterly Margin and Low Debt Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these high quarterly margin and low debt stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">TCS<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,71,423<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49,454<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.51%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.79%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.93%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Pidilite<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14,867.01<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,470.72<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.05%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.54%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Indian Hotels<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,971.43<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,195.14<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.19%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these high quarterly margin and low debt stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\"><\/span><strong>Institutional Holding in TCS, Sun Pharma, Pidilite and Indian Hotels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these high quarterly margin and low debt stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in TCS (from 12.01% to 13.47%), Sun Pharma (from 20.23% to 22.27%), Pidilite (from 9.15% to 9.88%) and Indian Hotels (from 18.52% to 24.59%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">TCS<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">71.77%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.06%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Pidilite<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">69.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Indian Hotels<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">38.12%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_High_Quarterly_Margin_and_Low_Debt_Stocks\"><\/span><strong>Risks to Weigh in High Quarterly Margin and Low Debt Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with high quarterly margin and low debt stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Pidilite trades at a PE of 56.50 against an industry PE of 36.15, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_High_Quarterly_Margin_and_Low_Debt_Stocks\"><\/span><strong>How to Choose Between High Quarterly Margin and Low Debt Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from high quarterly margin and low debt stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (18.27 to 36.77) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track TCS, Sun Pharma, Pidilite and Indian Hotels live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among high quarterly margin and low debt stocks, TCS stands out for the highest return on equity at 43.37%, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, Pidilite for the strongest latest-quarter profit growth at 30.29% and Indian Hotels for the biggest five-year price gain at 658.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high quarterly margin and low debt stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_High_Quarterly_Margin_and_Low_Debt_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on High Quarterly Margin and Low Debt Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_high_quarterly_margin_and_low_debt_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best high quarterly margin and low debt stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> TCS, Sun Pharma, Pidilite and Indian Hotels are the 4 names this list highlights, with market caps of Rs 8,31,455 crore, Rs 4,27,161 crore, Rs 1,51,179 crore and Rs 1,12,493 crore respectively. TCS is notable for the highest return on equity at 43.37%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Pidilite offers the strongest latest-quarter profit growth at 30.29%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for high quarterly margin and low debt stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_TCS_a_good_stock_for_long-term_investors\"><\/span><strong>Is TCS a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> TCS has a return on equity of 43.37%, a PE of 16.03 against an industry PE of 18.27 and a market cap of Rs 8,31,455 crore. Net profit has compounded at 6.49% a year since FY22, and FY26 revenue rose 4.68% while September 2026 quarter net profit grew 14.86%. Long-term returns in high quarterly margin and low debt stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high quarterly margin and low debt stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 35.25 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\"><\/span><strong>What is the market cap of TCS, Sun Pharma, Pidilite and Indian Hotels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 30 October 2026, TCS has a market cap of Rs 8,31,455 crore, Sun Pharma has a market cap of Rs 4,27,161 crore, Pidilite has a market cap of Rs 1,51,179 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high quarterly margin and low debt stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_high_quarterly_margin_and_low_debt_stocks\"><\/span><strong>What are the risks of investing in high quarterly margin and low debt stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Pidilite trades at a PE of 56.50 against an industry PE of 36.15, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Pidilite_trading_at_a_PE_of_5650\"><\/span><strong>Why is Pidilite trading at a PE of 56.50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pidilite&#8217;s PE of 56.50 compares with an industry PE of 36.15. The market is paying a premium for a return on equity of 22.61%, profit growth of 19.62% a year since FY22 and latest-quarter profit growth of 30.29%, which also means the stock is more sensitive if growth slows. Investors in high quarterly margin and low debt stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_TCS_Sun_Pharma_Pidilite_and_Indian_Hotels\"><\/span><strong>How much do institutions hold in TCS, Sun Pharma, Pidilite and Indian Hotels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 22.53% of TCS (9.06% and 13.47%), 36.63% of Sun Pharma (14.36% and 22.27%), 21.57% of Pidilite (11.69% and 9.88%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in high quarterly margin and low debt stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best high quarterly margin and low debt stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"TCS, Sun Pharma, Pidilite and Indian Hotels are the 4 names this list highlights, with market caps of Rs 8,31,455 crore, Rs 4,27,161 crore, Rs 1,51,179 crore and Rs 1,12,493 crore respectively. TCS is notable for the highest return on equity at 43.37%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Pidilite offers the strongest latest-quarter profit growth at 30.29%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for high quarterly margin and low debt stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is TCS a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"TCS has a return on equity of 43.37%, a PE of 16.03 against an industry PE of 18.27 and a market cap of Rs 8,31,455 crore. Net profit has compounded at 6.49% a year since FY22, and FY26 revenue rose 4.68% while September 2026 quarter net profit grew 14.86%. Long-term returns in high quarterly margin and low debt stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high quarterly margin and low debt stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 35.25 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of TCS, Sun Pharma, Pidilite and Indian Hotels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 30 October 2026, TCS has a market cap of Rs 8,31,455 crore, Sun Pharma has a market cap of Rs 4,27,161 crore, Pidilite has a market cap of Rs 1,51,179 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high quarterly margin and low debt stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in high quarterly margin and low debt stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Pidilite trades at a PE of 56.50 against an industry PE of 36.15, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Pidilite trading at a PE of 56.50?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pidilite's PE of 56.50 compares with an industry PE of 36.15. The market is paying a premium for a return on equity of 22.61%, profit growth of 19.62% a year since FY22 and latest-quarter profit growth of 30.29%, which also means the stock is more sensitive if growth slows. Investors in high quarterly margin and low debt stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in TCS, Sun Pharma, Pidilite and Indian Hotels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 22.53% of TCS (9.06% and 13.47%), 36.63% of Sun Pharma (14.36% and 22.27%), 21.57% of Pidilite (11.69% and 9.88%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in high quarterly margin and low debt stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap high quarterly margin and low debt stocks compared on market cap, PE, ROE, growth and institutional holding: TCS, Sun Pharma, Pidilite and Indian Hotels.<\/p>\n","protected":false},"author":33,"featured_media":334432,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[18888,18887],"class_list":["post-334433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-high-quarterly-margin-and-low-debt-sector","tag-high-quarterly-margin-and-low-debt-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["334432"],"rank_math_title":["High Quarterly Margin and Low Debt Stocks 2026: TCS, Sun Pharma"],"rank_math_description":["High quarterly margin and low debt stocks to watch for multibagger potential: TCS, Sun Pharma, Pidilite and Indian Hotels. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["high quarterly margin and low debt stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/4-largecap-high-quarterly-margin-and-low-debt-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=334433"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334433\/revisions"}],"predecessor-version":[{"id":334434,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334433\/revisions\/334434"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/334432"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=334433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=334433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=334433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}